文献速递创面修复显微修复重建

预防性应用人脂肪组织来源产品预防放射性疾病

Prophylactic Application of Human Adipose Tissue-Derived Products to Prevent Radiation Disorders.
PubMed 文献 · Plast Reconstr Surg · 2023-01-02

该探索性研究在裸鼠背部皮肤给予总剂量40 Gy(每次10 Gy,每周四次)放疗后,立即皮下注射溶媒、脂肪组织、基质血管组分或微细化细胞脂肪基质进行预防性治疗;6个月后制作皮肤打孔创面评估组织学变化与愈合。结果显示三种人脂肪组织来源产品均显著预防放射诱导的组织学改变并加速创面愈合,作者认为这是首项证明放疗后预防性治疗潜力的研究。

要点

  • 裸鼠背部皮肤接受总剂量40 Gy(10 Gy,每周四次)放疗后立即给予预防性治疗。
  • 放疗后6个月出现真皮增厚、萎缩、皮下脂肪层胶原沉积增加及创面愈合显著延迟。
  • 三种人脂肪组织来源产品均显著预防放射诱导的组织学改变并加速创面愈合(与溶媒对照照射组比较)。

核心结论

  • 这是首项证明放疗后预防性治疗潜力的研究,可能预防慢性放疗疾病进展。
  • 结果可能对当前抗癌放疗产生重大影响;下一代放疗可能需要始终联合干细胞治疗。
  • 此类预防性治疗有潜力改善照射组织的创面愈合及癌症放疗后所需重建手术的临床结局。

研究设计与样本

  • 探索性研究,将裸鼠背部皮肤接受总剂量40 Gy(10 Gy,每周四次)放疗后,皮下注射溶媒、脂肪组织、基质血管组分或微细化细胞脂肪基质进行预防性治疗。
  • 预防性治疗后6个月制作皮肤打孔创面,评估组织学变化与创面愈合。

主要发现

  • 放疗后6个月组织学评估显示真皮增厚、萎缩及皮下脂肪层胶原沉积增加。
  • 放疗后创面愈合显著延迟。
  • 与溶媒处理的照射组相比,三种不同人脂肪组织来源产品的预防性治疗均显著预防放射诱导的组织学改变并加速创面愈合。

临床怎么用

  • 作者认为,本研究结果提示使用干细胞疗法在临床上预防放射性疾病是可能的。
  • 作者提出,本研究可能提供预防性治疗的新概念,这将是放疗的范式转变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiation therapy is a mainstay treatment for malignancies, but it can induce deterministic adverse effects in surrounding healthy tissues, including atrophy, fibrosis, ischemia, and impaired wound healing. This exploratory study investigated whether prophylactic administration of products containing adipose tissue-derived stem cells immediately after radiotherapy could prevent the development of long-term functional disorders in irradiated tissues. METHODS: A total irradiation dose of 40 Gy (10 Gy, four times weekly) was delivered to the dorsal skin of nude mice. Subsequently, a prophylactic treatment with vehicle, fat tissue, stromal vascular fraction, or micronized cellular adipose matrix was injected subcutaneously into the irradiated area. Six months after these prophylactic treatments, a cutaneous punch wound was created to evaluate histologic changes and wound healing. RESULTS: Histologic assessments demonstrated dermal thickening, atrophy, and increased collagen deposits in the subcutaneous fatty layer 6 months after radiotherapy. In addition, wound healing was significantly delayed. The prophylactic treatments with three different types of human adipose tissue-derived products significantly prevented radiation-induced histologic changes and accelerated wound healing compared with the vehicle-treated irradiated group. CONCLUSIONS: This is the first study to demonstrate potential for prophylactic treatments after radiotherapy, which could prevent the progression of chronic radiation therapy disorders. The results could have a substantial impact on current anticancer radiotherapies; a next-generation radiation therapy may need to be always combined with a stem cell therapy. Such prophylactic treatments have the potential to improve wound healing of irradiated tissue and clinical outcomes of reconstructive surgery required after cancer radiotherapy. CLINICAL RELEVANCE STATEMENT: The results of this study suggest that it is clinically possible to prevent the development of radiation disorders using stem cell therapies. This study may provide a new concept of prophylactic treatment, which would be a paradigm shift in radiotherapy.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sowa Y, Inafuku N, Kishida T, et al. Prophylactic Application of Human Adipose Tissue-Derived Products to Prevent Radiation Disorders. Plast Reconstr Surg. 2023. PMID: 36728661. doi:10.1097/PRS.0000000000010132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。